stockrow
Saturday 7 November 2026
Export WVE’s income statement to Excel — free account
WAVE Life Sciences Ltd.
WAVE Life Sciences Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $42.7 million, down 60.5% from fiscal 2024.
- Revenue
- +73.0%
- EPS
- +5.25%
- Free cash flow
- −33.9%
Quarter to September 2026, against a year earlier
3.36
0.14
+4.35%
Follow WVE
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
3 | 2 | 4 | 2 | 5 | 5 | 3 | 3 | 3 | — |
Altman Z-Score |
11.34 | 2.72 | (4.04) | (10.94) | (6.14) | (3.76) | (3.97) | 0.24 | 13.80 | 15.35 |
P/S ratio |
67.10 | 15.79 | 5.00 | 133.98 | 3.23 | 15.38 | 16.99 | 84.49 | 237.00 | 547.06 |
Altman Z″-Score (non-manufacturers) |
0.83 | (7.05) | (12.47) | (28.05) | (13.50) | (8.66) | (9.18) | (5.42) | 2.04 | 8.29 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
(2.44) | (2.67) | — | — | — | (2.90) | (1.70) | 1.40 | — | — |
P/Operating CF |
(84.88) | (39.19) | (17.04) | (14.62) | (23.14) | (9.83) | (4.44) | (37.11) | (40.55) | (44.76) |
P/B ratio |
5.53 | 8.16 | 14.30 | 0.00 | 5.01 | 3.73 | 4.26 | 16.60 | 6.61 | 4.43 |
Price to Tangible BV |
5.53 | 8.16 | 14.30 | 0.00 | 5.01 | 3.73 | 4.26 | 16.60 | 6.61 | 4.43 |
EV/Sales |
53.01 | 13.00 | 3.23 | 109.74 | 0.24 | 6.19 | 7.79 | 72.37 | 200.40 | 409.44 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(12.08) | (9.33) | (18.85) | (3.13) | (0.14) | (1.07) | (0.66) | (45.63) | (9.32) | (14.00) |
EV/FCF |
(12.03) | (9.27) | (17.82) | (3.10) | (0.14) | (1.06) | (0.65) | (31.80) | (7.61) | (11.93) |
Quick Ratio |
6.35 | 2.74 | 1.19 | 1.24 | 2.35 | 1.77 | 1.41 | 1.42 | 7.89 | 12.36 |
Current Ratio |
6.47 | 2.89 | 1.26 | 1.38 | 2.53 | 1.90 | 1.57 | 1.56 | 8.27 | 12.50 |
Net Debt/EBITDA |
2.92 | 2.97 | 3.41 | 0.58 | 1.28 | 1.29 | 0.74 | 1.13 | 1.42 | 2.74 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.09 | 0.35 | 0.54 | 0.02 | 0.17 | 0.07 | 0.06 | 0.06 | 0.02 | 0.01 |
Operating CF/Net income |
0.92 | 1.56 | 0.34 | 0.79 | 0.73 | 0.77 | 0.97 | 0.16 | 0.82 | 0.57 |
Capex/Depreciation |
(0.08) | (0.11) | (0.12) | (0.12) | (0.06) | (0.13) | (0.43) | (2.07) | (9.70) | (7.10) |
| (56.16%) | (77.87%) | 2,106.32% | 2,570.05% | (212.09%) | (204.64%) | (282.52%) | (137.73%) | (74.31%) | (38.61%) | |
| (41.26%) | (30.94%) | (27.30%) | (91.58%) | (50.28%) | (53.21%) | (66.75%) | (61.39%) | (58.84%) | (33.71%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (1,284.77%) | 0.00% |
Return on Tangible Assets |
(38.77%) | (44.18%) | (92.74%) | (365.29%) | (101.34%) | (108.47%) | (186.75%) | (130.75%) | (63.88%) | (37.50%) |
Average Days of Receivables |
10.90 | 4.79 | 67.93 | 0.00 | 0.00 | 545.40 | 456.74 | 253.23 | 93.76 | 0.00 |
Research and Development Expense of Revenue |
427.78% | 147.44% | 114.74% | 3,175.01% | 297.52% | 652.21% | 1,097.61% | 932.62% | 2,037.22% | 3,737.91% |
Selling, General and Administrative Expense of Revenue |
176.31% | 54.50% | 45.27% | 1,384.30% | 112.55% | 211.73% | 305.76% | 274.10% | 692.91% | 1,464.65% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
58.45% | 12.13% | 8.64% | 471.20% | 40.05% | 71.21% | 122.06% | 108.20% | 311.92% | 627.01% |
Graham Net Nets |
0.17 | 0.10 | 0.00 | (0.19) | (0.07) | 0.11 | (0.13) | (0.02) | 0.13 | 0.22 |
Graham Number |
0.00 | 0.00 | 0.00 | 5.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(7.18%) | (6.31%) | (10.30%) | (34.35%) | (75.48%) | (50.57%) | (71.20%) | (12.04%) | (11.03%) | (9.20%) |
Free Cash Flow Yield |
(6.56%) | (8.88%) | (3.63%) | (26.39%) | (55.03%) | (38.00%) | (70.75%) | (2.69%) | (11.12%) | (6.28%) |
Revenue per Share |
0.25 | 0.78 | 1.07 | 0.05 | 0.79 | 0.51 | 0.47 | 0.50 | 0.15 | 0.05 |
Operating CF per Share |
(1.11) | (1.09) | (0.18) | (1.62) | (1.72) | (2.96) | (5.56) | (0.79) | (3.16) | (1.40) |
Capex per Share |
0.00 | (0.01) | (0.01) | (0.02) | (0.01) | (0.03) | (0.12) | (0.34) | (0.71) | (0.24) |
Free Cash Flow per Share |
(1.12) | (1.10) | (0.19) | (1.64) | (1.73) | (2.99) | (5.67) | (1.13) | (3.87) | (1.64) |
Cash per Share |
3.57 | 2.18 | 1.89 | 1.12 | 2.91 | 4.70 | 4.35 | 6.03 | 5.37 | 6.59 |
Shareholders Equity per Share |
3.07 | 1.52 | 0.37 | (0.57) | 0.63 | 2.11 | 1.88 | 2.53 | 5.56 | 6.26 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.07 | 1.52 | 0.37 | (0.57) | 0.63 | 2.11 | 1.88 | 2.53 | 5.56 | 6.26 |
Free Cash Flow |
(188.21) | (151.96) | (20.55) | (129.04) | (89.55) | (117.32) | (192.15) | (32.80) | (102.56) | (37.49) |
Working Capital |
519.75 | 209.44 | 48.93 | 27.02 | 98.36 | 109.00 | 67.32 | 72.23 | 132.30 | 139.84 |
Capital Expenditures |
(0.72) | (0.94) | (1.11) | (1.25) | (0.56) | (1.34) | (3.92) | (9.94) | (18.89) | (5.56) |
Net Current Asset Value |
494.67 | 177.70 | 0.05 | (92.94) | (11.94) | 33.58 | (35.04) | (20.32) | 116.13 | 129.92 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.01 | 0.01 | 0.34 | 0.01 | 0.07 | 0.25 | 0.69 | 4.85 | 5.09 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.20 | 0.86 | 0.70 | 0.59 | 0.44 | 0.34 | 0.25 | 0.12 | 0.07 | 0.09 |
Cash ROIC |
(16.80%) | (29.70%) | (8.56%) | (297.28%) | (48.92%) | (43.89%) | (91.11%) | (13.22%) | (35.37%) | (12.79%) |
Accounts Receivable Turnover |
31.67 | 9.62 | 4.44 | 0.00 | 0.00 | 0.80 | 1.07 | 2.62 | 6.49 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | — | — | — | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | — | — | — | — | — | — |
Average Receivables |
1.35 | 11.25 | 25.54 | — | — | 25.00 | 15.00 | 5.50 | 0.60 | — |
Average Payables |
15.98 | 14.55 | 14.88 | 12.10 | 10.54 | 11.43 | 11.08 | 10.34 | 6.27 | 3.88 |
Average Assets |
495.35 | 313.58 | 210.67 | 176.70 | 243.12 | 281.74 | 290.10 | 238.89 | 173.33 | 165.12 |
Average Common Equity |
363.94 | 124.57 | (2.73) | (6.30) | 57.64 | 73.26 | 68.54 | 106.48 | 137.24 | 144.18 |
Columns are period end dates · fundamentals updated 2 Nov 2026